Results 121 to 130 of about 14,827 (208)

Inhaled Levodopa for the Management of OFF Episodes in Parkinson's Disease: A Cost-Effectiveness Analysis. [PDF]

Pharmacoeconomics
Evans D, Mistry C, Knight H, Shah R, Guerra-Primo L, Gadeberg HC, Perni S, Clarke W, Brown J, Pietsch GA, Silas U, Carroll C.   +11 more
europepmc   +1 more source

Initiating Apomorphine Therapy Without Antiemetic Pretreatment: Real-World Data From a Nurse-led Parkinson Disease Support Program. [PDF]

J Neurosci Nurs
Happel C, Grall M, Formella A.
europepmc   +1 more source

Device aided therapies in Parkinson disease: an expert view on apomorphine. [PDF]

Neurol Sci
Stocchi F, Ceravolo R, Colosimo C, De Pandis MF, Modugno N, Pilleri M, Tessitore A, Tinazzi M, Valzania F, Vitale C, Zangaglia R, Zappia M, Zibetti M, Antonini A.   +13 more
europepmc   +1 more source

Correction to: Device aided therapies in Parkinson disease: an expert view on apomorphine. [PDF]

Neurol Sci
Stocchi F, Ceravolo R, Colosimo C, De Pandis MF, Modugno N, Pilleri M, Tessitore A, Tinazzi M, Valzania F, Vitale C, Zangaglia R, Zappia M, Zibetti M, Antonini A.   +13 more
europepmc   +1 more source

Neuroprotective effects of chrysin in a rat model of Parkinson's disease. [PDF]

Ann Med Surg (Lond)
Moradi S, Rajaei F, Darabi S.
europepmc   +1 more source

Subcutaneous apomorphine-induced pneumonitis: An uncommon pulmonary adverse event. [PDF]

Respir Med Case Rep
Barrueco-Otero E, Hidalgo-Sierra V, Piñero PT, Fernández IG, Pintor LG, Sánchez MB, Corbi Cobo-Losey MJ, Montilla C, Hernández-Mezquita MÁ.   +8 more
europepmc   +1 more source

Characterization of TRPV2-associated pathology in Parkinson's disease and therapeutic modulation using Tranilast. [PDF]

Front Cell Neurosci
Chunchuwar A, Vaidya B, Sharma SS.
europepmc   +1 more source

Efficacy and safety of apomorphine in the treatment of Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Ther Adv Neurol Disord
Abouelmagd ME, Abbas A, Yousef O, Abdelrahman Hassan A, Kassar O, Sarhan K, Zakria Alnajjar A, Sabet H, Ahmed Zanaty M, Awad H, Kashbour M, Almuzghi F, Barrett MJ, Berman B, Negida A.   +14 more
europepmc   +1 more source

Therapeutic Spectrum of Intermittent Apomorphine in Parkinson's Disease: Neuropsychiatric, Behavioral, and Cognitive Analyses. [PDF]

Noro Psikiyatr Ars
Ünal ED.
europepmc   +1 more source

Thalamic <i>Htr3a</i> Gene Expression in Hemi-Parkinsonian Rats Subjected to Persistent Pain. [PDF]

Brain Sci
Cortes-Altamirano JL, Alfaro-Rodríguez A, Reyes-Long S, Ortiz-Moreno FU, Bonilla-Jaime H, González-Maciel A, Pérez-Guille B, Soriano-Rosales RE, Reynoso-Robles R, Calderon-Guzman D, Juaréz-Olguín H.   +10 more
europepmc   +1 more source